AHR · American Healthcare REIT, Inc. · Documents

$57.78 -0.86 (-1.47%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$13.41B

232.07M

Volume · Nov 13 2.58M Avg daily vol (3M) 3.1M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025

May 8

Current report 8-K

Financial results, Regulation FD disclosure

Apr 10

Proxy statement DEF 14A

Proxy statement

Mar 19

Current report 8-K

Regulation FD disclosure, Other events

Feb 28

Earnings call

Q4 2024 earnings call

Feb 28

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $1.88B ▲ 12.9% Net loss $37.81M Diluted EPS -$0.29

Feb 27

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure

Feb 24

Current report 8-K Events of Feb 21

Charter or bylaw amendment, or fiscal year change

2024

Dec 18

Current report 8-K

Regulation FD disclosure, Other events

Nov 18

Current report 8-K

Entered into a material agreement

Nov 13

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $476.83M ▲ 14.6% Net loss $4.13M Diluted EPS -$0.03

Nov 12

Earnings call

Q3 2024 earnings call

Nov 12

Current report 8-K

Financial results, Regulation FD disclosure

Nov 8

Current report 8-K Events of Nov 7

Shareholder vote results

Sep 20

Current report 8-K Events of Sep 18

Entered into a material agreement, Other events

Sep 6

Current report 8-K

Regulation FD disclosure, Other events

Aug 28

Proxy statement DEF 14A

Proxy statement

Aug 12

Registration statement S-3ASR

Registration statement

Aug 9

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $458.01M ▲ 11.5% Net income $1.98M Diluted EPS $0.01

Aug 6

Earnings call

Q2 2024 earnings call

Aug 5

Current report 8-K

Financial results, Regulation FD disclosure

Jun 28

Current report 8-K Events of Jun 25

Shareholder director nominations

Jun 12

Current report 8-K

Regulation FD disclosure, Other events

Jun 3

Current report 8-K

Regulation FD disclosure

May 14

Earnings call

Q1 2024 earnings call

May 14

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $499.53M ▲ 10.5% Net loss $3.89M Diluted EPS -$0.04

May 13

Current report 8-K

Financial results, Regulation FD disclosure

Apr 10

Current report 8-K

Regulation FD disclosure

Mar 22

Earnings call

Q4 2023 earnings call

Mar 22

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $1.67B ▲ 18.2% Net loss $71.47M Diluted EPS -$1.08

Mar 21

Current report 8-K

Financial results, Regulation FD disclosure

Mar 15

Current report 8-K Events of Mar 12

Director or officer change, or executive pay, Regulation FD disclosure, Other events

Feb 21

Current report 8-K Events of Feb 14

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure

Feb 12

Current report 8-K Events of Feb 6

Entered into a material agreement, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure

Jan 30

Current report 8-K Events of Jan 26

Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure

Jan 11

Current report 8-K

Regulation FD disclosure

2023

Dec 15

Current report 8-K

Other events

Nov 20

Current report 8-K

Regulation FD disclosure

Nov 13

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $416.21M ▲ 13.0% Net loss $5.99M Diluted EPS -$0.09

Nov 7

Current report 8-K Events of Nov 3

Entered into a material agreement, Regulation FD disclosure

Oct 3

Current report 8-K

Regulation FD disclosure

Sep 20

Current report 8-K

Other events

Aug 29

Current report 8-K

Regulation FD disclosure

Aug 18

Current report 8-K

Regulation FD disclosure

Aug 14

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $410.62M ▲ 25.9% Net loss $12.18M Diluted EPS -$0.19

Jun 16

Current report 8-K Events of Jun 15

Shareholder vote results, Other events

Jun 15

Current report 8-K

Regulation FD disclosure

May 18

Current report 8-K

Regulation FD disclosure

May 15

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $408.63M ▲ 28.1% Net loss $25.87M Diluted EPS -$0.39

Apr 17

Proxy statement DEFA14A

Proxy statement

Apr 11

Proxy statement DEF 14A

Proxy statement

Showing 51–100 of 185 documents

Key facts CIK 1632970 CUSIP 398182303 13F (30d) 477 filings 438 filers Visit website Investor relations